Class information for:
Level 1: RHEUMATOID ARTHRITIS//ABATACEPT//TOCILIZUMAB

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1141 2826 40.9 84%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
316 3       RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL 39766
195 2             RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL 21443
1141 1                   RHEUMATOID ARTHRITIS//ABATACEPT//TOCILIZUMAB 2826

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 RHEUMATOID ARTHRITIS authKW 885941 45% 6% 1274
2 ABATACEPT authKW 745665 5% 51% 135
3 TOCILIZUMAB authKW 510286 6% 30% 156
4 ETANERCEPT authKW 416463 8% 17% 230
5 RHEUMATOLOGY WoSSC 345874 63% 2% 1787
6 ADALIMUMAB authKW 258399 6% 15% 165
7 RHEUMATOL address 245669 34% 2% 953
8 INFLIXIMAB authKW 211055 8% 9% 229
9 GOLIMUMAB authKW 191407 2% 37% 48
10 BIOLOGICS authKW 161686 5% 11% 134

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Rheumatology 345874 63% 2% 1787
2 Medicine, General & Internal 1066 10% 0% 296
3 Pharmacology & Pharmacy 918 13% 0% 364
4 Immunology 470 8% 0% 226
5 Health Care Sciences & Services 224 2% 0% 66
6 Medicine, Research & Experimental 141 4% 0% 109
7 Health Policy & Services 73 1% 0% 31
8 Allergy 16 1% 0% 16
9 Orthopedics 4 1% 0% 28
10 Primary Health Care 2 0% 0% 5

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 RHEUMATOL 245669 34% 2% 953
2 DANBIO 111116 0% 86% 12
3 NIHR LEEDS MUSCULOSKELETAL BIOMED UNIT 99580 2% 18% 50
4 ORTHOPED SURG RHEUMATOL 70895 1% 41% 16
5 UNIT CLIN THER Y 69122 1% 40% 16
6 METROPLEX CLIN 63541 0% 59% 10
7 RHEUMATOL UNIT 58416 6% 3% 159
8 LEEDS RHEUMAT MUSCULOSKELETAL MED 56790 1% 13% 40
9 CLINTRID 55558 0% 86% 6
10 G PINI ORTHOPED 52932 0% 70% 7

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 ANNALS OF THE RHEUMATIC DISEASES 130951 12% 4% 328
2 MODERN RHEUMATOLOGY 84151 4% 8% 100
3 RHEUMATOLOGY 59654 6% 3% 161
4 JOURNAL OF RHEUMATOLOGY 32788 7% 2% 197
5 CLINICAL AND EXPERIMENTAL RHEUMATOLOGY 30120 4% 2% 124
6 ARTHRITIS RESEARCH & THERAPY 27316 3% 3% 91
7 ZEITSCHRIFT FUR RHEUMATOLOGIE 23256 3% 3% 71
8 ARTHRITIS AND RHEUMATISM 19621 5% 1% 137
9 ARTHRITIS CARE & RESEARCH 19532 2% 3% 56
10 CLINICAL RHEUMATOLOGY 12229 3% 1% 78

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class		 LCSH search Wikipedia search
1 RHEUMATOID ARTHRITIS 885941 45% 6% 1274 Search RHEUMATOID+ARTHRITIS Search RHEUMATOID+ARTHRITIS
2 ABATACEPT 745665 5% 51% 135 Search ABATACEPT Search ABATACEPT
3 TOCILIZUMAB 510286 6% 30% 156 Search TOCILIZUMAB Search TOCILIZUMAB
4 ETANERCEPT 416463 8% 17% 230 Search ETANERCEPT Search ETANERCEPT
5 ADALIMUMAB 258399 6% 15% 165 Search ADALIMUMAB Search ADALIMUMAB
6 INFLIXIMAB 211055 8% 9% 229 Search INFLIXIMAB Search INFLIXIMAB
7 GOLIMUMAB 191407 2% 37% 48 Search GOLIMUMAB Search GOLIMUMAB
8 BIOLOGICS 161686 5% 11% 134 Search BIOLOGICS Search BIOLOGICS
9 BIOLOGIC DMARDS 153644 1% 89% 16 Search BIOLOGIC+DMARDS Search BIOLOGIC+DMARDS
10 TNF INHIBITORS 132511 2% 26% 47 Search TNF+INHIBITORS Search TNF+INHIBITORS

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 SINGH, JA , HOSSAIN, A , MAXWELL, LJ , GHOGOMU, ET , KOTB, A , CHRISTENSEN, R , MUDANO, AS , SHAH, NP , TUGWELL, P , WELLS, GA , (2016) BIOLOGICS OR TOFACITINIB FOR RHEUMATOID ARTHRITIS IN INCOMPLETE RESPONDERS TO METHOTREXATE OR OTHER TRADITIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 5. P. - 149 70% 3
2 SINGH, JA , HOSSAIN, A , GHOGOMU, ET , MUDANO, AS , TUGWELLA, P , WELLSB, GA , (2016) BIOLOGIC OR TOFACITINIB MONOTHERAPY FOR RHEUMATOID ARTHRITIS IN PEOPLE WITH TRADITIONAL DISEASE-MODIFYING ANTI-RHEUMATIC DRUG (DMARD) FAILURE: A COCHRANE SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS (NMA).COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 11. P. - 167 69% 0
3 MICHAUD, TL , RHO, YH , SHAMLIYAN, T , KUNTZ, KM , CHOI, HK , (2014) THE COMPARATIVE SAFETY OF TUMOR NECROSIS FACTOR INHIBITORS IN RHEUMATOID ARTHRITIS: A META-ANALYSIS UPDATE OF 44 TRIALS.AMERICAN JOURNAL OF MEDICINE. VOL. 127. ISSUE 12. P. 1208 -1232 151 53% 19
4 FURST, DE , KEYSTONE, EC , SO, AK , BRAUN, J , BREEDVELD, FC , BURMESTER, GR , DE BENEDETTI, F , DORNER, T , EMERY, P , FLEISCHMANN, R , ET AL (2013) UPDATED CONSENSUS STATEMENT ON BIOLOGICAL AGENTS FOR THE TREATMENT OF RHEUMATIC DISEASES, 2012.ANNALS OF THE RHEUMATIC DISEASES. VOL. 72. ISSUE . P. 2 -34 181 40% 34
5 LAHIRI, M , DIXON, WG , (2015) RISK OF INFECTION WITH BIOLOGIC ANTIRHEUMATIC THERAPIES IN PATIENTS WITH RHEUMATOID ARTHRITIS.BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY. VOL. 29. ISSUE 2. P. 290 -305 84 83% 9
6 SOUTO, A , MANEIRO, JR , GOMEZ-REINO, JJ , (2016) RATE OF DISCONTINUATION AND DRUG SURVIVAL OF BIOLOGIC THERAPIES IN RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF DRUG REGISTRIES AND HEALTH CARE DATABASES.RHEUMATOLOGY. VOL. 55. ISSUE 3. P. 523 -534 66 80% 5
7 EMERY, P , VENCOVSKY, J , SYLWESTRZAK, A , LESZCZYNSKI, P , PORAWSKA, W , BARANAUSKAITE, A , TSELUYKO, V , ZHDAN, VM , STASIUK, B , MILASIENE, R , ET AL (2017) A PHASE III RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP STUDY COMPARING SB4 WITH ETANERCEPT REFERENCE PRODUCT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE METHOTREXATE THERAPY.ANNALS OF THE RHEUMATIC DISEASES. VOL. 76. ISSUE 1. P. 51 -57 16 73% 20
8 LOPEZ-OLIVO, MA , TAYAR, JH , MARTINEZ-LOPEZ, JA , POLLONO, EN , CUETO, JP , GONZALES-CRESPO, MR , FULTON, S , SUAREZ-ALMAZOR, ME , (2012) RISK OF MALIGNANCIES IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH BIOLOGIC THERAPY A META-ANALYSIS.JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. VOL. 308. ISSUE 9. P. 898 -908 73 70% 104
9 NAM, JL , WINTHROP, KL , VAN VOLLENHOVEN, RF , PAVELKA, K , VALESINI, G , HENSOR, EMA , WORTHY, G , LANDEWE, R , SMOLEN, JS , EMERY, P , ET AL (2010) CURRENT EVIDENCE FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS WITH BIOLOGICAL DISEASE-MODIFYING ANTIRHEUMATIC DRUGS: A SYSTEMATIC LITERATURE REVIEW INFORMING THE EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF RA.ANNALS OF THE RHEUMATIC DISEASES. VOL. 69. ISSUE 6. P. 976 -986 58 79% 199
10 CHATZIDIONYSIOU, K , (2016) OPTIMIZING BIOLOGICAL TREATMENTS FOR RHEUMATOID ARTHRITIS.SCANDINAVIAN JOURNAL OF RHEUMATOLOGY. VOL. 45. ISSUE . P. 64 -75 56 97% 0

Classes with closest relation at Level 1


Rank Class id link
1 661 RHEUMATOID ARTHRITIS//RHEUMATOLOGY//EARLY RHEUMATOID ARTHRITIS
2 16155 INFLIXIMAB//DRUG INDUCED LUPUS//ADALIMUMAB
3 11785 WORK DISABILITY//WORK INSTABILITY//ARTHRIT COMMUNITY EVALUAT UNIT
4 33973 MDR I//RHEUMATOLOTA KU//BIOLOGIC AGENT THERAPY
5 14378 IMMUNODEFICIENCY ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS//LYMPHOPROLIFERATIVE DISORDERS//METHOTREXATE
6 23275 SYNOVIAL BIOPSY//SYNOVIAL TISSUE//SYNOVIAL BIOMARKERS
7 12217 LYMPHOTOXIN ALPHA//GALECTIN 2//TNF MICROSATELLITE
8 21548 HIP ARTHRODESIS//HIP FUSION//AG LES MARKUS KRANKENHAUS
9 3319 METHOTREXATE//RHEUMATOID ARTHRITIS//METHOTREXATE POLYGLUTAMATES
10 1645 INFLIXIMAB//CROHNS DISEASE//MUCOSAL HEALING

Go to start page